Analysis

After years of extreme price swings and tight supplies, the global coffee market is showing tentative signs of easing as...

While Orchid Island Capital itself has been quiet on the corporate news front recently, investors are far from idle. Market...

Investors are turning their attention to Palladyne AI as the company prepares to release a significant operational update. The anticipated...

Investors in U.S. Bancorp are currently exhibiting a cautious stance. With a lack of major company-specific catalysts, attention has shifted...

The market's attention is fixed on GameStop's substantial war chest. Under CEO Ryan Cohen's leadership, the company holds significant cash...

Eterna Therapeutics has drawn significant market attention following a substantial insider purchase and the release of an updated corporate strategy....

A powerful, multi-year upgrade cycle is fundamentally reshaping the landscape for optical network infrastructure. As strategic investments measured in the...

A notable divergence has emerged in the market's reaction to Lineage's latest financial report. While sell-side analysts maintain a guarded...

For Glori Energy, the days of operating as a functioning business are long gone. The company now exists as a...

The biopharmaceutical firm Helix BioPharma is intensifying its development of highly targeted cancer treatments. Recent data presentations for its CEACAM6-targeting...